Bristol-Myers Squibb

Bristol-Myers’ Opdivo gets FDA nod to treat small cell lung cancer

Bristol-Myers Squibb has received approval from the US Food and Drug Administration (FDA) for its Opdivo (nivolumab) medicine to treat…

BMS’ Sprycel secures European nod to treat Ph+ CML

Bristol-Myers Squibb (BMS) has secured approval from the European Commission (EC) for the use of its Sprycel (dasatinib) to treat…